Systematic Review of Compound Danshen Dropping Pill: A Chinese Patent Medicine for Acute Myocardial Infarction
Objective. This paper systematically evaluated the efficacy and safety of compound Danshen dropping pill (CDDP) in patients with acute myocardial infarction (AMI). Methods. Randomized controlled trials (RCTs), comparing CDDP with no intervention, placebo, or conventional western medicine, were retri...
Main Authors: | Jing Luo, Hao Xu, Keji Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/808076 |
Similar Items
-
Metabonomic Strategy to the Evaluation of Chinese Medicine Compound Danshen Dripping Pills Interfering Myocardial Ischemia in Rats
by: Xue Xin, et al.
Published: (2013-01-01) -
Recommendations on the Clinical Use of Compound Danshen Dripping Pills
by: Writing Group of Recommendations of Expert Panel from Chinese Geriatrics Society on the Clinical Use of Compound Danshen Dripping Pills
Published: (2017-01-01) -
Proangiogenesis effects of compound danshen dripping pills in zebrafish
by: Ding, R., et al.
Published: (2022) -
Elucidating direct kinase targets of compound Danshen dropping pills employing archived data and prediction models
by: Tongxing Wang, et al.
Published: (2021-05-01) -
Effect of compound danshen dropping pill on angina as well as serum c-reactive protein (CRP) and brain natriuretic peptide (BNP)
by: Jing Ye
Published: (2016-06-01)